{"_id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAwPn7ptgJDA","lastupdate":"2022-08-09T00:00:00.000Z","update_date":"2022-08-09T00:00:00.000Z","lastModified":"Feb 3, 2026","active":1,"confidence_score":100,"confidence_score_reason":"markets","urlname":"omnix-medical","minimal_profile":null,"status":"","fullstatus":"","acquired":0,"hide_reason":null,"hide_reason_data":null,"hide_reasons":[{"id":"8257rxn4P8EFQOmS5hAAauHyYMhhxrA5u6yWX4XUShpybX3AMNo3Y9","reason":"Pending approval - External entity"},{"id":"aOIaOiiqfpA8UMw6VCTh8ueRmkG3lzDy1NGqEOaJbe11OrCzMTCCd6","reason":"The company is a service provider"},{"id":"ddgjKuc3GgH8E5UehSVJviRl471BCajL1plO8HtGoOojy2NivYqQ7x","reason":"Owner asked to delete"},{"id":"EjOKM211H1ira9J63oaGPuUxvr7Oba55TZo3NWsFO5uhbNu7o4x4zD","reason":"The company is not Israeli"},{"id":"J7fQJtnT3GdWWSE3MD8rzaW65LJ4jEIKxSZnneQiReONdZjG3zIqWe","reason":"Owner asked to hide in the meantime"},{"id":"NxlAC3ReFb5ksiYNLp2FnUyluoJzwRCYfcF7xpTZaPM53SdWQ5kv0B","reason":"Pending approval"},{"id":"RhC1tlwXzioK0MfzBII3H2wepEfQOfKVktmdwqeqTJjGi3ZaBWUqZo","reason":"The company is not innovative"},{"id":"S0Ed46vNI6vZYVxLedANWGjas23K6hY0QdsCtiGYL7lshqIEdLV3sA","reason":"The company ceased operations in Israel"},{"id":"VTANq7bEvlsEcPjp0ghelXfShaCosgndONGjgU730aAOxXtaDIF5j3","reason":"This is a product of an existing company"}],"type":"Startup","logokey":"$5Mt8vOLPPOmgNXRNO8hbQ4Gi2NRClZOT1p0NSdVa2V36uwgPSsqwYr","name":"Omnix Medical","oneliner":"Novel Antibiotic Agents to Combat Resistant Bacteria","registrar":"515236784","website":"https://omnixmedical.com","careerspage":"https://omnixmedical.com/careers","founded_month":5,"founded_year":2015,"formernames":[],"sociallinks":{"twitter":"https://twitter.com/MedicalOmnix","youtube":"","facebook":"https://www.facebook.com/Omnix-Medical-Ltd-998177340289318","linkedin":"https://www.linkedin.com/company/13179766","instagram":""},"social":["https://www.facebook.com/Omnix-Medical-Ltd-998177340289318","https://www.linkedin.com/company/13179766","https://twitter.com/MedicalOmnix"],"flattenedsociallinks":"https://www.facebook.com/Omnix-Medical-Ltd-998177340289318|https://www.linkedin.com/company/13179766|https://twitter.com/MedicalOmnix","apps":{"appstore":"","googleplay":""},"is_claimed_by_owner":1,"employees":"11-50","employees_exact":24,"patent":1,"raised":51188300,"stage":"C","public_stage":"C","primary_sector_key":"agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","primary_sector":"Health Tech & Life Sciences","alternativenames":["Omnix","Onmix Medical"],"about":"Omnix Medical is a clinical-stage biopharmaceutical company developing next-generation of anti-infective drugs. We are determined to provide a safer, more efficient alternative to win the battle against AMR by offering therapies that are, by design, resilient against resistance development.\n\nOmnix Medical was founded in 2015 to address the urgent unmet need for new life-saving anti-infective drugs. Omnix´ proprietary technology eliminates bacteria by mimicking the innate immune system of insects which uses unique molecules to kill resistant bacterial strains efficiently and selectively without toxic effects. Omnix´ technology prevents the development of new resistances and is thus well positioned to become a first-line-treatment in a highly unmet need.\n\nThe Company’s lead compound, OMN6, is a novel, first-in-class antimicrobial peptide (AMP) based on insect host defense peptides. Its mechanism of action (MoA) is based on disruption of bacterial cell membranes and is therefore effective regardless of bacterial genotype or resistance phenotype, and unlike conventional bacteriostatic antibiotics, it is fast acting and bactericidal. \nOMN6 is being developed for the treatment of life-threatening hospital-acquired infections (HIA) caused by the Gram-negative bacteria Acinetobacter baumannii, and has shown significantly higher potency than currently available treatments.  \n\nRecently, Omnix has initiated a Phase 2 Proof-of-Concept trial of the company´s novel anti-infective OMN6 in HABP/VABP patients under IND approval from the FDA.\nOmnix team is hard at work with several active sights for the Phase 2 clinical trial as well as advancing our pipeline molecules and our mission to introduce new life-saving anti-infectives.\n\n","climatetech_description":null,"is_climatetech_relevant":null,"phone":"+972542386023","country":null,"address":{"israeli":[{"id":"4a6ff59c-840c-43ed-a63c-3be3613f2f3e","city":"Jerusalem","type":null,"address":"Givat Ram, Jerusalem, Israel","placeid":null,"notactive":0,"openeddate":null,"registrarid":null,"firstrdcenter":0,"registrarname":null}],"officesabroad":null},"headquarter_address":null,"district":"Jerusalem District","news":[{"id":"ZqBB5whjvUm620cfEh2nxsQvMRQX7u9JMTRO04ahERxTWSVqsT0616","date":"Oct 15, 2025","link":"https://www.calcalistech.com/ctechnews/article/hjqrmrnpgl?utm_medium=editorial-push&utm_source=taboola","source":"www.calcalistech.com","visible":1,"analysis":{"tags":"funding, antibiotic-resistance","round":"Series C","company":"Omnix Medical","layoffs":null,"summary":"Omnix Medical, an Israeli biopharmaceutical company, has secured $25 million in a Series C funding round led by Harel Insurance & Finance and the European Innovation Council (EIC) Fund. The funding will support the completion of Phase II clinical trials for its lead compound, OMN6, aimed at treating antibiotic-resistant infections. The company plans to use the funds for regulatory preparations, manufacturing scale-up, and further development of its antimicrobial peptide pipeline. OMN6 has received Fast-Track and Qualified Infectious Disease Product status from the FDA, highlighting its potential in combating drug-resistant bacteria.","partners":null,"customers":null,"eventType":null,"investors":["Harel Insurance & Finance","European Innovation Council (EIC) Fund","Entrée Capital","Tal Ventures","Xenia Ventures","Oriella Limited","Prevail Partners","OurCrowd"],"confidence":9,"key_topics":["antibiotic-resistance","funding","clinical trials","biopharmaceutical","FDA approval"],"date_of_event":null,"product_stage":"Phase II clinical trial","investment_date":null,"acquired_company":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":"$25 million","structured_issues":["Investment","Product Stage"],"acquisition_amount":null,"FDA approved/pending approval":"pending approval","AI technology developing/using":"not mentioned","structuredIssuesShow":"#Investment  #Product Stage","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"ZbhSuKnxyWNSJ86aouqivmX226KCMBgK9xybZfiNzBfIO1gER174p8","news_summary":"Omnix Medical raises $25 million Series C to tackle drug-resistant infections | CTech","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"GPS9wDVPitbfxf3VMwu3Vn9Uj5PcVAt212pk9bhoz8zE0EqBhxjovn","date":"Oct 15, 2025","link":"https://www.calcalistech.com/ctechnews/article/hjqrmrnpgl","source":"www.calcalistech.com","visible":1,"analysis":{"tags":"antibiotic-resistance","round":"Series C","company":"Omnix Medical","layoffs":null,"summary":"Omnix Medical, an Israeli biopharmaceutical company, has secured $25 million in a Series C funding round led by Harel Insurance & Finance and the European Innovation Council Fund. The funding will support the completion of Phase II trials for their lead compound, OMN6, which targets antibiotic-resistant infections. The compound has received Fast-Track and QIDP status from the FDA. The investment will also aid in regulatory preparations, manufacturing scale-up, and the development of other antimicrobial peptides. Omnix has raised a total of $43 million since its inception in 2015.","partners":null,"customers":null,"eventType":null,"investors":["Harel Insurance & Finance","European Innovation Council (EIC) Fund","Entrée Capital","Tal Ventures","Xenia Ventures","Oriella Limited","Prevail Partners","OurCrowd"],"confidence":10,"key_topics":["antibiotics","funding","clinical trials","bacterial resistance","biopharmaceutical"],"date_of_event":null,"product_stage":"Phase II","investment_date":null,"acquired_company":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":"$25 million","structured_issues":["Investment","Product Stage"],"acquisition_amount":null,"FDA approved/pending approval":"pending approval","AI technology developing/using":"not mentioned","structuredIssuesShow":"#Investment  #Product Stage","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"grY8gWEC4ckQ4Zn24p7fS2BKb51w91eM6F8POJCJqGTt7Arh9U3uIj","news_summary":"Israeli biotech secures funding to complete Phase II trials for its novel antimicrobial peptide therapy.","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"6ca8476d-1094-4a44-8f83-e33f58953237","date":"Jan 26, 2021","link":"https://www.calcalistech.com/ctech/articles/0,7340,L-3889749,00.html","source":"www.calcalistech.com","visible":1,"analysis":{"tags":"biopharmaceutical, funding","company":"Omnix Medical","layoffs":null,"summary":"Omnix Medical, an Israeli biopharmaceutical company, has been awarded €10.8 million in EU funding to develop next-generation anti-infectives for the treatment of antibiotic-resistant infections. The funding is part of the EUs Horizon 2020 program for research and innovation. Omnix Medicals novel agents are designed as an alternative to classical antibiotics, targeting bacterial membranes to destroy bacteria regardless of existing resistances. The funding will allow the company to advance its lead compound OMN6 through clinical proof-of-concept studies. Omnix Medical has raised a total of €20 million to date from investors including Tal Capital, Entrée Capital, the CBG Group, Xenia Ventures, and VLX Ventures. Dr. Antonius Schuh has been appointed as Chairman of the Board of Directors.","partners":null,"customers":null,"investors":"Tal Capital, Entrée Capital, the CBG Group, Xenia Ventures, VLX Ventures","confidence":9,"key_topics":["Omnix Medical","EU funding","antibiotic resistance","novel agents","clinical proof-of-concept studies"],"date_of_event":"2021-01-26","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Investment"],"acquisition_amount":null,"structuredIssuesShow":"#Investment","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"DPJMkwPyjaAIeZiHsfYPheQ5KSV9FTQVCN65SJ1akkRveJvHc2eYEU","news_summary":"Israeli biopharma startup Omnix Medical awarded €10.8 million from EU to fight drug-resistant bacteria","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"cab54f89-4de1-4ebc-aaaa-9777aaf935fd","date":"Nov 3, 2020","link":"https://www.calcalistech.com/ctech/articles/0,7340,L-3868294,00.html","source":"www.calcalistech.com","visible":1,"analysis":{"tags":"antibiotic development","company":"Omnix Medical","layoffs":null,"summary":"Omnix Medical, an Israeli startup developing novel antibiotic agents, has completed an $8.5 million funding round led by Tal Capital and Entrée Capital. The funding will allow the company to begin clinical trials with humans after successfully completing testing in animals. Omnix Medical plans to test its flagship solution, OMN6, which represents a new antibiotic class with a rapid-bactericidal effect. The company aims to bring groundbreaking and life-saving technology to the market. Omnix Medical was founded by Dr. Moshik Cohen-Kutner, Dr. Niv Bachnoff, and Rom Lakritz, who developed their solution based on the immune systems of insects. The company has raised a total of $10 million since its founding in 2015.","partners":null,"customers":null,"investors":["Tal Capital","Entrée Capital","CBG Group","Xenia Ventures","VLX Ventures","Israel Innovation Authority"],"confidence":9,"key_topics":["Antibiotic development","Funding","Clinical trials","Unique mechanism of action","Life-saving technology"],"date_of_event":"2020-11-03","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":"$8.5 million","structured_issues":["Investment"],"acquisition_amount":null,"structuredIssuesShow":"#Investment","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"3yBdp5DwtAwfdH0RYW4ftKVj9e3do10PZZg0Q1p7G4d2gBFGClr9RH","news_summary":"Omnix Medical completes $8.5 million round to develop next-generation antibiotics for treatment of life-threatening infections","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"7ba2995d-bed7-4e92-b3cf-bc79706006d9","date":"Jan 31, 2019","link":"https://www.jpost.com/HEALTH-SCIENCE/A-cure-for-cancer-Despite-one-companys-claims-many-experts-are-uncertain-579362","source":"www.jpost.com","visible":1,"analysis":{"tags":"Cancer Cure Controversy","company":"Accelerated Evolution Biotechnologies Ltd. (AEBi)","layoffs":"Not mentioned","summary":"Israeli company Accelerated Evolution Biotechnologies Ltd. (AEBi) has faced criticism after claiming to have discovered a cure for cancer. The claim was made by AEBis chairman of the board, Dan Aridor, and its CEO, Dr. Ilan Morad, who said their treatment, MuTaTo, is essentially a cancer antibiotic. However, experts have disputed the claim, stating that the research is far from proven. Despite the criticism, AEBi maintains that the treatment will be available for testing on humans within a year.","partners":"Not mentioned","customers":"Not mentioned","investors":"Not mentioned","confidence":8,"key_topics":"Cancer Cure, Clinical Trials, Criticism, Patents, Peptide-based Drugs","date_of_event":"Not mentioned","valuation_amount":"Not mentioned","impact_on_company":"growth-negative","investment_amount":"Not mentioned","structured_issues":"Customers, Investment","acquisition_amount":"Not mentioned","structuredIssuesShow":"#Customers, Investment","entityGrowthIconPath":"url(/assets/circle-red.svg);"},"sentiment":"growth-negative","analysisId":"Ui7ozQgZSpUapivDmLXMllzmoc9AX4nsG0SdkdKUaO0Gpgae0rGRS7","news_summary":"https://www.jpost.com/HEALTH-SCIENCE/A-cure-for-cancer-Despite-one-companys-claims-many-experts-are-uncertain-579362","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"}],"newsNumber":5,"techcommunityinvolvement":null,"mediagallery":[{"id":"IEZaAOpHg1fE7B3OpSRHqoPdXath7iopxE7x2fVyxuQHHZJBCU7B6x","timestamp":"2024-12-16 12:17:15.000000","resources_type":2,"resources_title":"Omnix Medical","resources_file_name":"y2tTd60L5Jg","alt":"Omnix Medical logo","imageurl":"https://img.youtube.com/vi/y2tTd60L5Jg/0.jpg","url":"http://youtu.be/y2tTd60L5Jg"},{"id":"8f9e8e99-d62a-4773-a706-d2b48b23223c","timestamp":"2018-05-06 13:02:48.000000","resources_type":2,"resources_title":"","resources_file_name":"MN5g-rAZv7g","alt":"","imageurl":"https://img.youtube.com/vi/MN5g-rAZv7g/0.jpg","url":"http://youtu.be/MN5g-rAZv7g"}],"tags":["drug-discovery","patients","pharmaceuticals","infection","bacteria","hospitals","doctors"],"classificationIDs":["agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Jvz7ewLDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety_cIDA"],"technologysuccessstory":null,"usecases":[],"businessmodels":["B2B"],"productstage":"Clinical Trial","products":["OMN-71","OMN-51","OMN6"],"geomarkets":["United States","Global"],"targetmarkets":[],"marketcapital":null,"marketcapitaldate":null,"funding":{"investors":11,"lastfunding":"$25M","totalrounds":6,"fundingstage":"C","totalfunding":"$51.19M","publicinvestors":10,"lastpublicfunding":25000000,"totalpublicrounds":5,"totalpublicfunding":50438300},"team":[{"name":"Moshik  Cohen-Kutner","email":"moshik@omnixmedical.com","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAwPnnrMYJDA","bounced":false,"claimed":0,"founder":1,"urlname":"moshik-cohen-kutner-1","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgIDA-a6ZkgsM","position":"Co-founder & CEO","last_name":"Cohen-Kutner","claimtoken":"e83ObZpcgd28wBH7VhbYLMHzSWqMvNKH9VVgNXrspouvdhicCglszB","first_name":"Moshik ","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/moshik-cohen-kutner-phd-194a1843/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2024-03-27 15:09:30.000000","initials":"MC","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Rom  Lakritz","email":"rom@omnixmedical.com","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAoMmN0J4LDA","bounced":false,"claimed":0,"founder":1,"urlname":"rom-lakritz-1","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgICgia_asgkM","position":"Co-founder & CFO & COO","last_name":"Lakritz","claimtoken":"f476820d86a0f92ad4b2935b11448de18aa01acbd68f24a3babe3b6b0aedcfd1","first_name":"Rom ","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/rom-lakritz-668b4352/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2022-08-09 17:04:04.000000","initials":"RL","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Niv Bachnoff","email":"niv@omnixmedical.com","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAoObU74IKDA","bounced":false,"claimed":1,"founder":1,"urlname":"niv-bachnoff-1","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgIDA-dG9iAkM","position":"Co-founder & CSO","last_name":"Bachnoff","claimtoken":"12b03a43cac03de27f68270d4ef0ac18b43814e758ed53bd272a83d2da165cfa","first_name":"Niv","picturekey":"$hoc9W9kQqBYI3yKptkzhBi2E3OObgK8fCbSg4KNah1HlsSpfSEA3c4","claimeddate":"2018-11-22","linkedinurl":"https://www.linkedin.com/in/niv-bachnoff-13170a23","unsubscribed":false,"is_activeuser":1,"additionalemail":"niv.bach@mail.huji.ac.il","claimedemaildate":"2018-11-22 07:21:08.000000","initials":"","pictureurl":"https://storage.googleapis.com/clean-finder-353810/$hoc9W9kQqBYI3yKptkzhBi2E3OObgK8fCbSg4KNah1HlsSpfSEA3c4","linkedin-display":"flex","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"ffff llll","email":"1@1.com","phone":"","gender":"Other","userid":"NoAIcfHgvJa91ZFOHEqLuEoPh1EkZd0RmfAZozsgUxUtsQvpFUGvw0","bounced":false,"claimed":null,"founder":0,"urlname":"ffff-llll","visible":1,"memberid":"llCtZttlC02ECNMrd1aKfG6DT8rPMqBC4YS4JWNlcSGKWDZcc0oAvH","position":"","last_name":"llll","claimtoken":null,"first_name":"ffff","picturekey":null,"claimeddate":null,"linkedinurl":null,"unsubscribed":false,"is_activeuser":0,"additionalemail":"","claimedemaildate":null,"initials":"FL","pictureurl":"/assets/empty-state.svg","linkedin-display":"none","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Du Hy","email":"duhypu@denipl.net","phone":"","gender":"Male","userid":"MNGyM8RLIxIQjiJxYCv5wPyUdoJQ03gO9wEbXNfg5WSDf1CzP2K2Sj","bounced":false,"claimed":null,"founder":0,"urlname":"du-hy","visible":1,"memberid":"mN4YbrSKpE0m8HMwuXJfmgiqEVdjvVGOIKzGEoQCtbtk0tANWjkgpo","position":"","last_name":"Hy","claimtoken":null,"first_name":"Du","picturekey":null,"claimeddate":null,"linkedinurl":null,"unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":null,"initials":"DH","pictureurl":"/assets/empty-state.svg","linkedin-display":"none","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"","visibilityTooltip":""}],"description_edited":1,"tag_line_edited":1,"sector":"Pharmaceuticals","sectorverify":{"id":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAgPGylJ0IDA","fullname":"Natalia Golczar"},"biverify":{"id":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAgPGylJ0IDA","fullname":"Natalia Golczar"},"biverifydate":"2020-03-19T00:00:00.000Z","crunchbaseid":"omnix-medical","lastupdator":"Yanina Wainscheinker","lastupdator_email":"yanina.wain@gmail.com","creator":"Josh Taban","creator_email":"joshtaban@gmail.com","createdate":"2016-12-27T00:00:00.000Z","biverification":"Natalia Golczar","sectorverification":"Natalia Golczar","affiliatedOrganizations":null,"timeline":[{"id":"KQGqoB3tDlZBeiE42qkpNEm1tMwZJxEmaJbZGxEetIbbQ7NvohW1qk","date":"Oct 2025","amount":"$25M","source":"https://www.calcalistech.com/ctechnews/article/hjqrmrnpgl +tal ventures silent round, Estrella from OurCrowd","eventtype":"FundingRoundEvent","investment":[{"name":"European Innovation Council","type":"Investor","amount":null,"hidden":false,"country":"Belgium","fullurl":"/investor_page/european-innovation-council","logokey":"$BM8t5Nw7HzAiqGbGUipDDhCefh8oinehng6mftX5R55QqxvAAyPLau","tagline":"","urlname":"/investor_page/european-innovation-council","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOC7qIihCww","fundingtype":"Incubator","leadpartner":null,"investmentid":"I0hYUq18on2aRbjcYXRBpmpEjvbYlI0kl2W0AzqeYMvZMISSABq3oo","fundingsubtype":"Incubator","investorislead":1,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$BM8t5Nw7HzAiqGbGUipDDhCefh8oinehng6mftX5R55QqxvAAyPLau","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"Lead&nbsp;","followupcaption":""},{"name":"Harel Insurance & Finance","type":"Investor","amount":null,"hidden":false,"country":"Israel","fullurl":"/investor_page/harel-insurance-finance","logokey":"$eer3trCbMymhkw74aHRrv9S0RWCWy2WY5QqJwAgg20sbhhQTXZrk0k","tagline":null,"urlname":"/investor_page/harel-insurance-finance","isisraeli":1,"investorid":"7IA52i2eTfWfJysCrQqMc9KYgUk2NiYwEDYRYWntmIvgUwfrOmjt2F","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"MZvtprMvmciRcHgap5mVL6JoAjWuBhYhXoGR1HOjOdQGvvrxOwZC4t","fundingsubtype":"VC and Private Equity","investorislead":1,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$eer3trCbMymhkw74aHRrv9S0RWCWy2WY5QqJwAgg20sbhhQTXZrk0k","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"Lead&nbsp;","followupcaption":""},{"name":"Entrée Capital","type":"Investor","amount":null,"hidden":false,"country":"Israel","fullurl":"/investor_page/entr-e-capital","logokey":"$hGR2j5fYNcPTG4toUBBdxEi1bamaVcEXUqC4URRp6O9Ipv6S4shHjZ.png","tagline":null,"urlname":"/investor_page/entr-e-capital","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgNmJ7oMJDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"0LQ4nY7r06EeZe0QfEFWARr8jGBkO78eEaBovSQhK6GodLhckmcDEK","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":1,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$hGR2j5fYNcPTG4toUBBdxEi1bamaVcEXUqC4URRp6O9Ipv6S4shHjZ.png","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":"Follow on&nbsp;"},{"name":"Tal Ventures","type":"Investor","amount":null,"hidden":false,"country":"Israel","fullurl":"/investor_page/tal-capital","logokey":"$14amJausY0Agqsfwm9AbA25Dy9UCXStytKXB5cjED3v4XZm0pmAP6u","tagline":null,"urlname":"/investor_page/tal-capital","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4PGjr50KDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"5JklEdayi3lP0ImxIsIyRmEzDRIx17jxcP4HwZ399sJRuOE4PJo11Q","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":1,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$14amJausY0Agqsfwm9AbA25Dy9UCXStytKXB5cjED3v4XZm0pmAP6u","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":"Follow on&nbsp;"},{"name":"OurCrowd","type":"Investor","amount":null,"hidden":false,"country":"Israel","fullurl":"/investor_page/ourcrowd","logokey":"$7IbHrXXd8dSbWrifZtvAYNCvwQvEjxCgGJeOg7DXKENs3TbpV3W9g1","tagline":null,"urlname":"/investor_page/ourcrowd","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgP7H-oQKDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"6wMkv5rXU6Q9oxF6pgkOgXE1eKGhWNtbib5jtrE7q9aRtSLjgl5XBo","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":1,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$7IbHrXXd8dSbWrifZtvAYNCvwQvEjxCgGJeOg7DXKENs3TbpV3W9g1","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":"Follow on&nbsp;"},{"name":"Xenia Venture Capital","type":"Investor","amount":null,"hidden":false,"country":"Israel","fullurl":"/investor_page/xenia-venture-capital","logokey":"$MfqF5WmAKFiams13nTMLjr0ZOy38PqXIOUgyA5BitfcqqGAkeKEBmb","tagline":null,"urlname":"/investor_page/xenia-venture-capital","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgNGDmIcKDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"P7ovDCSaPZxHtsxURJioq31FbSEwatfLHjPT1bwZADQyDEudlKBgDY","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":1,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$MfqF5WmAKFiams13nTMLjr0ZOy38PqXIOUgyA5BitfcqqGAkeKEBmb","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":"Follow on&nbsp;"},{"name":"Prevail Partners","type":"Investor","amount":null,"hidden":true,"country":"United States","fullurl":"/investor_page/prevail-partners","logokey":"$mTEb7cLAg22aoyFn2zIQOS3s72DJKDgDip6kXgOmdf37FsLGvJ1hFI.jpeg","tagline":null,"urlname":"/investor_page/prevail-partners","isisraeli":0,"investorid":"yS8Arx0ialdbKpmm5KRqoj2KRNBTgEsUgDzDNGuFOYzBr9YOocpAzg","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"QKfifiIeEnhZvxD9Z1HsxM2f99dqZw7hUUvsD40k3ZLzftDqDRssEu","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$mTEb7cLAg22aoyFn2zIQOS3s72DJKDgDip6kXgOmdf37FsLGvJ1hFI.jpeg","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"C Round","style":"","hiddenCompanyTooltip":"","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","sectionname":"Private Equity Funding","amountnumber":25000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"4F0NYFXxhvFbupyDc5WgiCdLO01hJBTtXHHJwUzPlmbnEj4StXTmk7","date":"Feb 2025","amount":"$438.3K","source":"","eventtype":"FundingRoundEvent","investment":[{"name":"OurCrowd","type":"Investor","amount":null,"hidden":false,"country":"Israel","fullurl":"/investor_page/ourcrowd","logokey":"$7IbHrXXd8dSbWrifZtvAYNCvwQvEjxCgGJeOg7DXKENs3TbpV3W9g1","tagline":null,"urlname":"/investor_page/ourcrowd","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgP7H-oQKDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"hHDc1lVEwVAJLD400iYiEWmgZjcyEHgzaRZyJXtjQ3O81hRtyBQsUH","fundingsubtype":"VC and Private Equity","investorislead":1,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$7IbHrXXd8dSbWrifZtvAYNCvwQvEjxCgGJeOg7DXKENs3TbpV3W9g1","leadcaption":"Lead&nbsp;","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Undisclosed Round","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":438300,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"tCXwVLYo6F3b3xv7vXGk3M5cqn8mOq2JeeQ1sY1rw1JtclSkxLUFQO","date":"Jan 2021","amount":"$13M","source":"https://www.calcalistech.com/ctech/articles/0,7340,L-3889749,00.html","eventtype":"GrantEvent","granttype":1,"investment":[{"name":"EIC Accelerator","type":"Accelerator","amount":null,"hidden":true,"country":"Belgium","fullurl":"/program_page/eic-accelerator","logokey":null,"tagline":"EIC Accelerator is an accelerator managed by the European Innovation Council and European Commission (EC) based in Brussels, Belgium. The firm seeks to support small and medium enterprises.","urlname":"/program_page/eic-accelerator","isisraeli":0,"investorid":"DSnozIu4tFaENytWcT1Y4Wzro134ttf9vwbDP23n82MplEWezRgvpQ","fundingtype":"General","leadpartner":null,"investmentid":"OsqIGBeZK84qqTptqlT8dDfM5IQPntyDFj5NkstrQYcdkIzeFfae35","fundingsubtype":"General","investorislead":1,"amountvisibility":"Public","isextensionround":null,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"/assets/hubs-icon.svg","leadcaption":"Lead&nbsp;","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":null,"isjointventuregrant":0,"fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Non-Equity Funding","isgrant":true,"isicoevent":false,"amountnumber":13000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCd9MKdCww","date":"Nov 2020","amount":"$8.5M","source":"https://www.calcalistech.com/ctech/articles/0,7340,L-3868294,00.html","eventtype":"FundingRoundEvent","investment":[{"name":"Entrée Capital","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/entr-e-capital","logokey":"$hGR2j5fYNcPTG4toUBBdxEi1bamaVcEXUqC4URRp6O9Ipv6S4shHjZ.png","tagline":null,"urlname":"/investor_page/entr-e-capital","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgNmJ7oMJDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"3q4gZSg7xFeKcK6CUbTUTZqNoInYICgFWL1me5zSBAzmRuTYzuEmpO","fundingsubtype":"VC and Private Equity","investorislead":1,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":null,"leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$hGR2j5fYNcPTG4toUBBdxEi1bamaVcEXUqC4URRp6O9Ipv6S4shHjZ.png","leadcaption":"Lead&nbsp;","followupcaption":""},{"name":"Tal Ventures","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/tal-capital","logokey":"$14amJausY0Agqsfwm9AbA25Dy9UCXStytKXB5cjED3v4XZm0pmAP6u","tagline":null,"urlname":"/investor_page/tal-capital","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4PGjr50KDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"XoWAb663SA036KDF8mEX20AMLGfhyZcPPvZLAHAcUUJvtmgAxwyeqc","fundingsubtype":"VC and Private Equity","investorislead":1,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":null,"leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$14amJausY0Agqsfwm9AbA25Dy9UCXStytKXB5cjED3v4XZm0pmAP6u","leadcaption":"Lead&nbsp;","followupcaption":""},{"name":"Israel Innovation Authority","type":"Government","amount":0,"hidden":false,"country":"Israel","fullurl":"/company_page/israel-innovation-authority-4","logokey":"$5c4LgWLzukZDi2b9IlcK1cbez0QSOoXpTLU21Y4ByNtfkRvqOSLs8L","tagline":"","urlname":"/company_page/israel-innovation-authority-4","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOC20eTwCQw","fundingtype":"Government","leadpartner":null,"investmentid":"Za5aWD2UOj231SUFQ4nWIIdGyRo5eeBWX3xywrof99a5Em2L6TyyDk","fundingsubtype":"","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":1,"investorvisibility":null,"leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$5c4LgWLzukZDi2b9IlcK1cbez0QSOoXpTLU21Y4ByNtfkRvqOSLs8L","leadcaption":"","followupcaption":"Follow on&nbsp;"},{"name":"Xenia Venture Capital","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/xenia-venture-capital","logokey":"$MfqF5WmAKFiams13nTMLjr0ZOy38PqXIOUgyA5BitfcqqGAkeKEBmb","tagline":null,"urlname":"/investor_page/xenia-venture-capital","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgNGDmIcKDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"qRSqIOwAyz2QLDlRPttJ5b8PHu9BFTValpF0OJtbO8F7li6ODWllL1","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":null,"leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$MfqF5WmAKFiams13nTMLjr0ZOy38PqXIOUgyA5BitfcqqGAkeKEBmb","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"A Round","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":8500000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCE7qWhCQw","date":"Dec 2018","amount":"$3.5M","source":"Migrated","eventtype":"FundingRoundEvent","investment":[{"name":"Undisclosed Investor(s)","type":"Investor","amount":0,"hidden":false,"country":"Europe","fullurl":"/investor_page/undisclosed-investor-s","logokey":null,"tagline":"","urlname":"/investor_page/undisclosed-investor-s","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCE3L3CCgw","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"6c8b15cc-fd7c-4d01-9ad5-7e41c4305ce4","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"/assets/investors-icon.svg","leadcaption":"","followupcaption":""},{"name":"Israel Innovation Authority","type":"Government","amount":0,"hidden":false,"country":"Israel","fullurl":"/company_page/israel-innovation-authority-4","logokey":"$5c4LgWLzukZDi2b9IlcK1cbez0QSOoXpTLU21Y4ByNtfkRvqOSLs8L","tagline":"","urlname":"/company_page/israel-innovation-authority-4","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOC20eTwCQw","fundingtype":"Government","leadpartner":null,"investmentid":"7a95d790-57f3-4f35-b80b-6d081c6cac15","fundingsubtype":"","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$5c4LgWLzukZDi2b9IlcK1cbez0QSOoXpTLU21Y4ByNtfkRvqOSLs8L","leadcaption":"","followupcaption":""},{"name":"Docor International Management","type":"Investor","amount":null,"hidden":false,"country":"Israel","fullurl":"/investor_page/docor","logokey":"$OfHtk8MQpXyjuEfISyRNC2I0FArnwi7SC4uowUIF3xWUco4YnAg2VW","tagline":null,"urlname":"/investor_page/docor","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgMnYj5YKDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"KTGWCy7VXBTBbmKKgIQbr4Mumt67bYfICabRrslkwPVIVCuzrcQlEa","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$OfHtk8MQpXyjuEfISyRNC2I0FArnwi7SC4uowUIF3xWUco4YnAg2VW","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Seed","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":3500000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCEjcX-CQw","date":"May 2015","amount":"$750K","source":"Migrated","eventtype":"FundingRoundEvent","investment":[{"name":"VLX Ventures","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/vlx","logokey":"$dXu7ZEAH5LAowXCtVDAvI4T3opiaicfOFgluzyyEJuZioaeoMbfNc4","tagline":null,"urlname":"/investor_page/vlx","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgLHYycwJDA","fundingtype":"Incubator","leadpartner":null,"investmentid":"1a852040-c02e-4259-ac10-9c0bc7b03279","fundingsubtype":"Incubator","investorislead":null,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$dXu7ZEAH5LAowXCtVDAvI4T3opiaicfOFgluzyyEJuZioaeoMbfNc4","leadcaption":"","followupcaption":""}],"eventvisibility":"Internal","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Seed","visibilityClassName":"private-visibility","visibilityTooltip":"tooltip tooltip-html-content='<style>\n    .visibility-tooltip-container {\n        display: flex;\n        column-gap: 0.8rem;\n        padding: 0.8rem 1rem;\n        align-items: center;\n    } \n\n    .visibility-tooltip-container text {\n        font-size: 1.4rem;\n        text-transform: capitalize;\n        font-weight: 500;\n    }\n</style>\n\n<div class=\"visibility-tooltip-container\">\n    <img height=\"20\" width=\"20\" style=\"display: none\" src=\"/assets/private-visibility.svg\"/>\n    <img height=\"20\" width=\"20\" style=\"display: flex\" src=\"/assets/internal-visibility.svg\"/>\n    <text>Internal</text>\n</div>'","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":750000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"eZVuCENyfQQqHYKCg3c46wyRPsI3AvfQOMjOvvFUFvM5GlzasZUFmO","hub":"BioGiv","date":"","batch":"","amount":"Undisclosed","hub_id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4NyEhJIKDA","source":"","enddate":"","hub_type":"Entrepreneurship Program","eventtype":"GraduationEvent","hub_hidden":false,"investment":[],"hub_fullurl":"/program_page/biogiv","hub_logokey":"$s6g12I1QNPxaMzuKNWZSQjc4FOWLALyqm22Yc3vZTNkPsRlmvrNqM0","hub_urlname":"/program_page/biogiv","eventvisibility":null,"amountvisibility":null,"fundingvisibility":null,"style":"","hiddenCompanyTooltip":"","hub_logourl":"https://storage.googleapis.com/clean-finder-353810/$s6g12I1QNPxaMzuKNWZSQjc4FOWLALyqm22Yc3vZTNkPsRlmvrNqM0","amountnumber":null,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"investmentstage":[],"exits":[],"investments":[],"portfolio":[],"funds":[],"founded":"5/2015","databases":[],"sharedspaces":[],"utilities":[],"contributors":[],"employeesworldwide":"","fundingtype":"Startup","parsedName":"Omnix Medical","logourl":"https://storage.googleapis.com/clean-finder-353810/$5Mt8vOLPPOmgNXRNO8hbQ4Gi2NRClZOT1p0NSdVa2V36uwgPSsqwYr","oglogourl":"https://storage.googleapis.com/clean-finder-353810/$5Mt8vOLPPOmgNXRNO8hbQ4Gi2NRClZOT1p0NSdVa2V36uwgPSsqwYr","seoabout":"Omnix Medical is a clinical-stage biopharmaceutical company developing next-generation of anti-infective drugs. We are determined to provide a safer, more ...","seoTitle":"Israeli Startup","solutions":[],"teamMembersNumber":5,"primarySector":"Health Tech & Life Sciences","primary-sector-display":"block","classifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Health Tech & Life Sciences","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Pharma & Medical Biotechnology","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA","classificationName":"sectorclassification"},{"depth":3,"name":"Drugs Discovery & Development","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety_cIDA","classificationName":"sectorclassification"},{"depth":0,"name":"Core Technology","queryString":"coretechnology=undefined","classificationName":"coretechnology"},{"depth":1,"name":"Biologicals","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA","classificationName":"coretechnology"},{"depth":2,"name":"Molecules","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Jvz7ewLDA","classificationName":"coretechnology"},{"depth":0,"name":"Target Customer","queryString":"targetcustomer=undefined","classificationName":"targetcustomer"},{"depth":1,"name":"Healthcare & Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA","classificationName":"targetcustomer"},{"depth":3,"name":"Pharmaceuticals","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA","classificationName":"targetcustomer"}],"classificationDelimited":["SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA","TechnologyClassificationModel>Biologicals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA>Molecules#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Jvz7ewLDA","TechnologyClassificationModel>Biologicals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA>Pharmaceuticals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA>Drugs Discovery & Development#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety_cIDA"],"classificationsViewModel":"|0:>SectorClassificationModel|1:>SectorClassificationModel/Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA|2:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA/Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA|3:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA/Drugs Discovery & Development#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety_cIDA|0:>TechnologyClassificationModel|1:>TechnologyClassificationModel/Biologicals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA|2:>TechnologyClassificationModel>Biologicals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA/Molecules#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Jvz7ewLDA|0:>IndustryClassificationModel|1:>IndustryClassificationModel/Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA|2:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA/Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA|3:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA/Pharmaceuticals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA|","classificationTrees":{"sector":[{"title":"Health Tech & Life Sciences","key":"0-0","path":"SectorClassificationModel>Health Tech & Life Sciences","children":[{"title":"Pharma & Medical Biotechnology","key":"0-0-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Pharma & Medical Biotechnology","children":[{"title":"Drugs Discovery & Development","key":"0-0-0-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Pharma & Medical Biotechnology>Drugs Discovery & Development"}]}]}],"targetCustomer":[{"title":"Healthcare & Life Sciences","key":"0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences","children":[{"title":"Life Sciences","key":"0-0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Life Sciences","children":[{"title":"Pharmaceuticals","key":"0-0-0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Life Sciences>Pharmaceuticals"}]}]}],"coreTechnology":[{"title":"Biologicals","key":"0-0","path":"TechnologyClassificationModel>Biologicals","children":[{"title":"Molecules","key":"0-0-0","path":"TechnologyClassificationModel>Biologicals>Molecules"}]}]},"sectorClassifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Health Tech & Life Sciences","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Pharma & Medical Biotechnology","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA","classificationName":"sectorclassification"},{"depth":3,"name":"Drugs Discovery & Development","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety_cIDA","classificationName":"sectorclassification"}],"coreTechnologyClassifications":[{"depth":0,"name":"Core Technology","queryString":"coretechnology=undefined","classificationName":"coretechnology"},{"depth":1,"name":"Biologicals","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA","classificationName":"coretechnology"},{"depth":2,"name":"Molecules","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Jvz7ewLDA","classificationName":"coretechnology"}],"targetCustomerClassifications":[{"depth":0,"name":"Target Customer","queryString":"targetcustomer=undefined","classificationName":"targetcustomer"},{"depth":1,"name":"Healthcare & Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA","classificationName":"targetcustomer"},{"depth":3,"name":"Pharmaceuticals","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA","classificationName":"targetcustomer"}],"classificationNames":{"sector":["Health Tech & Life Sciences","Pharma & Medical Biotechnology","Drugs Discovery & Development"],"coreTechnology":["Biologicals","Molecules"],"targetCustomer":["Healthcare & Life Sciences","Life Sciences","Pharmaceuticals"]},"section":null,"sectionParams":"","queryParams":"","popup_claim_profile":"false","claimedBadge":"inline","display":{"mainContact":"none","climateTag":"none","seeMoreSimilarCompanisDisplay":"none","similarCompaniesTitleFontSize":"3.2rem","similarCompaniesTitle":"Similar Companies","similar_companies":[]},"mainContact":{},"_eventview":{"publicoffering_exit":[],"privateequityfunding":[{"id":"KQGqoB3tDlZBeiE42qkpNEm1tMwZJxEmaJbZGxEetIbbQ7NvohW1qk","date":"Oct 2025","amount":"$25M","source":"https://www.calcalistech.com/ctechnews/article/hjqrmrnpgl +tal ventures silent round, Estrella from OurCrowd","eventtype":"FundingRoundEvent","investment":[{"name":"European Innovation Council","type":"Investor","amount":null,"hidden":false,"country":"Belgium","fullurl":"/investor_page/european-innovation-council","logokey":"$BM8t5Nw7HzAiqGbGUipDDhCefh8oinehng6mftX5R55QqxvAAyPLau","tagline":"","urlname":"/investor_page/european-innovation-council","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOC7qIihCww","fundingtype":"Incubator","leadpartner":null,"investmentid":"I0hYUq18on2aRbjcYXRBpmpEjvbYlI0kl2W0AzqeYMvZMISSABq3oo","fundingsubtype":"Incubator","investorislead":1,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$BM8t5Nw7HzAiqGbGUipDDhCefh8oinehng6mftX5R55QqxvAAyPLau","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"Lead&nbsp;","followupcaption":""},{"name":"Harel Insurance & Finance","type":"Investor","amount":null,"hidden":false,"country":"Israel","fullurl":"/investor_page/harel-insurance-finance","logokey":"$eer3trCbMymhkw74aHRrv9S0RWCWy2WY5QqJwAgg20sbhhQTXZrk0k","tagline":null,"urlname":"/investor_page/harel-insurance-finance","isisraeli":1,"investorid":"7IA52i2eTfWfJysCrQqMc9KYgUk2NiYwEDYRYWntmIvgUwfrOmjt2F","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"MZvtprMvmciRcHgap5mVL6JoAjWuBhYhXoGR1HOjOdQGvvrxOwZC4t","fundingsubtype":"VC and Private Equity","investorislead":1,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$eer3trCbMymhkw74aHRrv9S0RWCWy2WY5QqJwAgg20sbhhQTXZrk0k","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"Lead&nbsp;","followupcaption":""},{"name":"Entrée Capital","type":"Investor","amount":null,"hidden":false,"country":"Israel","fullurl":"/investor_page/entr-e-capital","logokey":"$hGR2j5fYNcPTG4toUBBdxEi1bamaVcEXUqC4URRp6O9Ipv6S4shHjZ.png","tagline":null,"urlname":"/investor_page/entr-e-capital","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgNmJ7oMJDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"0LQ4nY7r06EeZe0QfEFWARr8jGBkO78eEaBovSQhK6GodLhckmcDEK","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":1,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$hGR2j5fYNcPTG4toUBBdxEi1bamaVcEXUqC4URRp6O9Ipv6S4shHjZ.png","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":"Follow on&nbsp;"},{"name":"Tal Ventures","type":"Investor","amount":null,"hidden":false,"country":"Israel","fullurl":"/investor_page/tal-capital","logokey":"$14amJausY0Agqsfwm9AbA25Dy9UCXStytKXB5cjED3v4XZm0pmAP6u","tagline":null,"urlname":"/investor_page/tal-capital","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4PGjr50KDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"5JklEdayi3lP0ImxIsIyRmEzDRIx17jxcP4HwZ399sJRuOE4PJo11Q","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":1,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$14amJausY0Agqsfwm9AbA25Dy9UCXStytKXB5cjED3v4XZm0pmAP6u","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":"Follow on&nbsp;"},{"name":"OurCrowd","type":"Investor","amount":null,"hidden":false,"country":"Israel","fullurl":"/investor_page/ourcrowd","logokey":"$7IbHrXXd8dSbWrifZtvAYNCvwQvEjxCgGJeOg7DXKENs3TbpV3W9g1","tagline":null,"urlname":"/investor_page/ourcrowd","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgP7H-oQKDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"6wMkv5rXU6Q9oxF6pgkOgXE1eKGhWNtbib5jtrE7q9aRtSLjgl5XBo","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":1,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$7IbHrXXd8dSbWrifZtvAYNCvwQvEjxCgGJeOg7DXKENs3TbpV3W9g1","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":"Follow on&nbsp;"},{"name":"Xenia Venture Capital","type":"Investor","amount":null,"hidden":false,"country":"Israel","fullurl":"/investor_page/xenia-venture-capital","logokey":"$MfqF5WmAKFiams13nTMLjr0ZOy38PqXIOUgyA5BitfcqqGAkeKEBmb","tagline":null,"urlname":"/investor_page/xenia-venture-capital","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgNGDmIcKDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"P7ovDCSaPZxHtsxURJioq31FbSEwatfLHjPT1bwZADQyDEudlKBgDY","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":1,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$MfqF5WmAKFiams13nTMLjr0ZOy38PqXIOUgyA5BitfcqqGAkeKEBmb","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":"Follow on&nbsp;"},{"name":"Prevail Partners","type":"Investor","amount":null,"hidden":true,"country":"United States","fullurl":"/investor_page/prevail-partners","logokey":"$mTEb7cLAg22aoyFn2zIQOS3s72DJKDgDip6kXgOmdf37FsLGvJ1hFI.jpeg","tagline":null,"urlname":"/investor_page/prevail-partners","isisraeli":0,"investorid":"yS8Arx0ialdbKpmm5KRqoj2KRNBTgEsUgDzDNGuFOYzBr9YOocpAzg","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"QKfifiIeEnhZvxD9Z1HsxM2f99dqZw7hUUvsD40k3ZLzftDqDRssEu","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$mTEb7cLAg22aoyFn2zIQOS3s72DJKDgDip6kXgOmdf37FsLGvJ1hFI.jpeg","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"C Round","style":"","hiddenCompanyTooltip":"","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","sectionname":"Private Equity Funding","amountnumber":25000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"4F0NYFXxhvFbupyDc5WgiCdLO01hJBTtXHHJwUzPlmbnEj4StXTmk7","date":"Feb 2025","amount":"$438.3K","source":"","eventtype":"FundingRoundEvent","investment":[{"name":"OurCrowd","type":"Investor","amount":null,"hidden":false,"country":"Israel","fullurl":"/investor_page/ourcrowd","logokey":"$7IbHrXXd8dSbWrifZtvAYNCvwQvEjxCgGJeOg7DXKENs3TbpV3W9g1","tagline":null,"urlname":"/investor_page/ourcrowd","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgP7H-oQKDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"hHDc1lVEwVAJLD400iYiEWmgZjcyEHgzaRZyJXtjQ3O81hRtyBQsUH","fundingsubtype":"VC and Private Equity","investorislead":1,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$7IbHrXXd8dSbWrifZtvAYNCvwQvEjxCgGJeOg7DXKENs3TbpV3W9g1","leadcaption":"Lead&nbsp;","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Undisclosed Round","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":438300,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCd9MKdCww","date":"Nov 2020","amount":"$8.5M","source":"https://www.calcalistech.com/ctech/articles/0,7340,L-3868294,00.html","eventtype":"FundingRoundEvent","investment":[{"name":"Entrée Capital","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/entr-e-capital","logokey":"$hGR2j5fYNcPTG4toUBBdxEi1bamaVcEXUqC4URRp6O9Ipv6S4shHjZ.png","tagline":null,"urlname":"/investor_page/entr-e-capital","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgNmJ7oMJDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"3q4gZSg7xFeKcK6CUbTUTZqNoInYICgFWL1me5zSBAzmRuTYzuEmpO","fundingsubtype":"VC and Private Equity","investorislead":1,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":null,"leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$hGR2j5fYNcPTG4toUBBdxEi1bamaVcEXUqC4URRp6O9Ipv6S4shHjZ.png","leadcaption":"Lead&nbsp;","followupcaption":""},{"name":"Tal Ventures","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/tal-capital","logokey":"$14amJausY0Agqsfwm9AbA25Dy9UCXStytKXB5cjED3v4XZm0pmAP6u","tagline":null,"urlname":"/investor_page/tal-capital","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4PGjr50KDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"XoWAb663SA036KDF8mEX20AMLGfhyZcPPvZLAHAcUUJvtmgAxwyeqc","fundingsubtype":"VC and Private Equity","investorislead":1,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":null,"leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$14amJausY0Agqsfwm9AbA25Dy9UCXStytKXB5cjED3v4XZm0pmAP6u","leadcaption":"Lead&nbsp;","followupcaption":""},{"name":"Israel Innovation Authority","type":"Government","amount":0,"hidden":false,"country":"Israel","fullurl":"/company_page/israel-innovation-authority-4","logokey":"$5c4LgWLzukZDi2b9IlcK1cbez0QSOoXpTLU21Y4ByNtfkRvqOSLs8L","tagline":"","urlname":"/company_page/israel-innovation-authority-4","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOC20eTwCQw","fundingtype":"Government","leadpartner":null,"investmentid":"Za5aWD2UOj231SUFQ4nWIIdGyRo5eeBWX3xywrof99a5Em2L6TyyDk","fundingsubtype":"","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":1,"investorvisibility":null,"leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$5c4LgWLzukZDi2b9IlcK1cbez0QSOoXpTLU21Y4ByNtfkRvqOSLs8L","leadcaption":"","followupcaption":"Follow on&nbsp;"},{"name":"Xenia Venture Capital","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/xenia-venture-capital","logokey":"$MfqF5WmAKFiams13nTMLjr0ZOy38PqXIOUgyA5BitfcqqGAkeKEBmb","tagline":null,"urlname":"/investor_page/xenia-venture-capital","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgNGDmIcKDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"qRSqIOwAyz2QLDlRPttJ5b8PHu9BFTValpF0OJtbO8F7li6ODWllL1","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":null,"leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$MfqF5WmAKFiams13nTMLjr0ZOy38PqXIOUgyA5BitfcqqGAkeKEBmb","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"A Round","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":8500000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCE7qWhCQw","date":"Dec 2018","amount":"$3.5M","source":"Migrated","eventtype":"FundingRoundEvent","investment":[{"name":"Undisclosed Investor(s)","type":"Investor","amount":0,"hidden":false,"country":"Europe","fullurl":"/investor_page/undisclosed-investor-s","logokey":null,"tagline":"","urlname":"/investor_page/undisclosed-investor-s","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCE3L3CCgw","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"6c8b15cc-fd7c-4d01-9ad5-7e41c4305ce4","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"/assets/investors-icon.svg","leadcaption":"","followupcaption":""},{"name":"Israel Innovation Authority","type":"Government","amount":0,"hidden":false,"country":"Israel","fullurl":"/company_page/israel-innovation-authority-4","logokey":"$5c4LgWLzukZDi2b9IlcK1cbez0QSOoXpTLU21Y4ByNtfkRvqOSLs8L","tagline":"","urlname":"/company_page/israel-innovation-authority-4","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOC20eTwCQw","fundingtype":"Government","leadpartner":null,"investmentid":"7a95d790-57f3-4f35-b80b-6d081c6cac15","fundingsubtype":"","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$5c4LgWLzukZDi2b9IlcK1cbez0QSOoXpTLU21Y4ByNtfkRvqOSLs8L","leadcaption":"","followupcaption":""},{"name":"Docor International Management","type":"Investor","amount":null,"hidden":false,"country":"Israel","fullurl":"/investor_page/docor","logokey":"$OfHtk8MQpXyjuEfISyRNC2I0FArnwi7SC4uowUIF3xWUco4YnAg2VW","tagline":null,"urlname":"/investor_page/docor","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgMnYj5YKDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"KTGWCy7VXBTBbmKKgIQbr4Mumt67bYfICabRrslkwPVIVCuzrcQlEa","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$OfHtk8MQpXyjuEfISyRNC2I0FArnwi7SC4uowUIF3xWUco4YnAg2VW","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Seed","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":3500000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCEjcX-CQw","date":"May 2015","amount":"$750K","source":"Migrated","eventtype":"FundingRoundEvent","investment":[{"name":"VLX Ventures","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/vlx","logokey":"$dXu7ZEAH5LAowXCtVDAvI4T3opiaicfOFgluzyyEJuZioaeoMbfNc4","tagline":null,"urlname":"/investor_page/vlx","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgLHYycwJDA","fundingtype":"Incubator","leadpartner":null,"investmentid":"1a852040-c02e-4259-ac10-9c0bc7b03279","fundingsubtype":"Incubator","investorislead":null,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$dXu7ZEAH5LAowXCtVDAvI4T3opiaicfOFgluzyyEJuZioaeoMbfNc4","leadcaption":"","followupcaption":""}],"eventvisibility":"Internal","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Seed","visibilityClassName":"private-visibility","visibilityTooltip":"tooltip tooltip-html-content='<style>\n    .visibility-tooltip-container {\n        display: flex;\n        column-gap: 0.8rem;\n        padding: 0.8rem 1rem;\n        align-items: center;\n    } \n\n    .visibility-tooltip-container text {\n        font-size: 1.4rem;\n        text-transform: capitalize;\n        font-weight: 500;\n    }\n</style>\n\n<div class=\"visibility-tooltip-container\">\n    <img height=\"20\" width=\"20\" style=\"display: none\" src=\"/assets/private-visibility.svg\"/>\n    <img height=\"20\" width=\"20\" style=\"display: flex\" src=\"/assets/internal-visibility.svg\"/>\n    <text>Internal</text>\n</div>'","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":750000,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"nonequityfunding":[{"id":"tCXwVLYo6F3b3xv7vXGk3M5cqn8mOq2JeeQ1sY1rw1JtclSkxLUFQO","date":"Jan 2021","amount":"$13M","source":"https://www.calcalistech.com/ctech/articles/0,7340,L-3889749,00.html","eventtype":"GrantEvent","granttype":1,"investment":[{"name":"EIC Accelerator","type":"Accelerator","amount":null,"hidden":true,"country":"Belgium","fullurl":"/program_page/eic-accelerator","logokey":null,"tagline":"EIC Accelerator is an accelerator managed by the European Innovation Council and European Commission (EC) based in Brussels, Belgium. The firm seeks to support small and medium enterprises.","urlname":"/program_page/eic-accelerator","isisraeli":0,"investorid":"DSnozIu4tFaENytWcT1Y4Wzro134ttf9vwbDP23n82MplEWezRgvpQ","fundingtype":"General","leadpartner":null,"investmentid":"OsqIGBeZK84qqTptqlT8dDfM5IQPntyDFj5NkstrQYcdkIzeFfae35","fundingsubtype":"General","investorislead":1,"amountvisibility":"Public","isextensionround":null,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"/assets/hubs-icon.svg","leadcaption":"Lead&nbsp;","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":null,"isjointventuregrant":0,"fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Non-Equity Funding","isgrant":true,"isicoevent":false,"amountnumber":13000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"merger_acquisitions":[],"others":[]}}